EcoDrugPlus

Potassium Voltage-Gated Channel, Shal-Related Subfamily, Member 3

Ensembl ID : ENSSMAG00000007465
Gene Symbol: KCND3
1 Cross references
192 Possible Orthologues:

Potassium-Transporting Atpase Subunit Beta-Like

Ensembl ID : ENSSMAG00000021311
Gene Symbol: LOC118302858
2 Cross references
184 Possible Orthologues:

Presenilin 1

Ensembl ID : ENSSMAG00000009396
Gene Symbol: PSEN1
2 Cross references
200 Possible Orthologues:

Presenilin 2

Ensembl ID : ENSSMAG00000033295
Gene Symbol: PSEN2
2 Cross references
205 Possible Orthologues:

Presenilin Enhancer, Gamma-Secretase Subunit

Ensembl ID : ENSSMAG00000000756
Gene Symbol: PSENEN
3 Cross references
183 Possible Orthologues:

Probable Histone Deacetylase 1-B

Ensembl ID : ENSSMAG00000009073
Gene Symbol: LOC118286006
2 Cross references
76 Possible Orthologues:

Progesterone Receptor

Ensembl ID : ENSSMAG00000001689
Gene Symbol: PGR
3 Cross references
193 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSSMAG00000022432
Gene Symbol: LOC118312448
2 Cross references
145 Possible Orthologues:

Prostaglandin D2 Receptor 2-Like

Ensembl ID : ENSSMAG00000029096
Gene Symbol: LOC118300066
2 Cross references
134 Possible Orthologues:

Prostaglandin D2 Receptor 2-Like

Ensembl ID : ENSSMAG00000028327
Gene Symbol: LOC118300065
2 Cross references
134 Possible Orthologues:

Prostaglandin E Receptor 1a (Subtype Ep1)

Ensembl ID : ENSSMAG00000008320
Gene Symbol: PTGER1A
3 Cross references
167 Possible Orthologues:

Prostaglandin E Receptor 2a (Subtype Ep2)

Ensembl ID : ENSSMAG00000011189
Gene Symbol: PTGER2A
3 Cross references
202 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).